Back to Search
Start Over
Safety of concurrent bevacizumab therapy and anticoagulation in high-grade glioma patients
- Source :
- Journal of Clinical Oncology. 28:2043-2043
- Publication Year :
- 2010
- Publisher :
- American Society of Clinical Oncology (ASCO), 2010.
-
Abstract
- 2043 Background: Venous thromboembolic events (VTE) are common in glioblastoma (GBM) patients, and bevacizumab increases the risk of VTE. There is little information on the risk of anticoagulation ...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 28
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........dec870660f2fb1bb5cf2862beda955f5
- Full Text :
- https://doi.org/10.1200/jco.2010.28.15_suppl.2043